Vaxcyte, Inc. Quarterly Depreciation, Depletion and Amortization in USD from Q1 2020 to Q1 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
-
Summary
-
Vaxcyte, Inc. quarterly/annual Depreciation, Depletion and Amortization history and growth rate from Q1 2020 to Q1 2024.
- Vaxcyte, Inc. Depreciation, Depletion and Amortization for the quarter ending March 31, 2024 was $999K, a 40.3% increase year-over-year.
- Vaxcyte, Inc. annual Depreciation, Depletion and Amortization for 2023 was $3.16M, a 22.5% increase from 2022.
- Vaxcyte, Inc. annual Depreciation, Depletion and Amortization for 2022 was $2.58M, a 43.2% increase from 2021.
- Vaxcyte, Inc. annual Depreciation, Depletion and Amortization for 2021 was $1.8M, a 28.1% increase from 2020.
Depreciation, Depletion and Amortization, Quarterly (USD)
Depreciation, Depletion and Amortization, YoY Quarterly Growth (%)